Laurus Labs to acquire 52% of SI&C Resins for ₹33 crore

Mergers & acquisitions
pharmaceuticals and chemicals

Blacklitt Research29 October 20262 min read

Laurus Labs (NSE: LAURUSLABS) has approved buying a 52% stake in SI & C Resins Private Limited for ₹32.50 crore in cash, it said in a filing on 29 Oct 2026. The company says the deal extends its peptide manufacturing business into resins and chromatography gels.

What is being bought and why

The deal is a primary subscription: Laurus Labs will take 10,833 new equity shares, equal to 52% of SI&C's equity capital after the issue, for ₹32.50 crore. The pre-money valuation of SI&C is ₹30 crore.

The company says the acquisition is part of its overall Peptide strategy and will make its peptide manufacturing fully integrated. It adds that SI&C will set up a large-scale plant for peptide resins used as solid phase peptide synthesis supports, and for chromatography gels.

SI&C makes polymer and silica-based products for the chemical, pharmaceutical and biotechnology industries, including peptide synthesis and the separation of heavy metals. It was incorporated on 15 Jul 2026 in Hyderabad, and will take over the business of a partnership firm, M/s SI & C Resins, whose partners are its founder directors and shareholders.

Scale and the further investment

The partnership firm reported turnover of ₹3.55 crore in FY 2024-25 and ₹4.05 crore in FY 2025-26. Against Laurus Labs' latest quarterly total income of ₹2,035.49 crore, the initial ₹32.50 crore is a small step, though the filing does not state what share of the group's revenue SI&C will add.

Separately, the company may invest up to ₹30 crore more in securities issued by SI&C as and when SI&C needs funds.

What the SI&C stake means for Laurus Labs' shareholders

The company will hold 52% of SI&C after closing, which will then be a subsidiary, and the initial cheque is ₹32.50 crore paid in cash. Closing is expected during the current financial year, subject to customary conditions, including the transfer of the partnership firm's business.

The filing does not say what the deal will add to Laurus Labs' results, when closing will happen, or on what terms the business will be transferred. It also does not give the timing or conditions of the further ₹30 crore.

At a glance

Item	Detail
Target	SI & C Resins Private Limited, Hyderabad
Incorporated	15 Jul 2026
Stake acquired	52% of post-issue equity capital
Shares subscribed	10,833 equity shares
Investment	₹32.50 crore in cash
Pre-money valuation	₹30 crore
Further investment	Up to ₹30 crore in SI&C securities, as required
Board approval	29 Oct 2026

Reference: Original filing (PDF)

Sign up to continue reading

Create a free account to read the rest of this article and the analysis that follows.

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.